BioSpace News Archive

Ultivue, a life science company developing reagent-driven strategies for high-performance biological imaging in situ, today announced expanded capabilities of its proprietary InSituPlex® DNA-barcoding and staining technology.

BERG LLC today announced four abstracts showcasing the value of its Back to Biology™ approach in identifying disease signatures and mechanisms of Parkinson’s disease (PD) and other neurological disorders were presented at the annual meeting of the Society for Neuroscience (SfN) in San Diego, California, Nov. 3-7, 2018.

Quarterly Dividend Increased 40%, Driven by Strong Revenue and AFFO Growth

Synlogic, Inc. (Nasdaq: SYBX), announced today that the Company will release its third quarter 2018 financial results after the market closes on Tuesday, November 13, 2018.

Bausch Health Companies Inc. announced today that it has commenced a cash tender offer (the “Tender Offer”) to purchase any and all of its outstanding 7.500% Senior Notes due 2021

Nu Skin Enterprises, Inc. (NYSE: NUS) today announced strong third-quarter financial results with revenue of $675.3 million, an increase of 20 percent over the prior-year period.

Trovagene, Inc. today announced company highlights and financial results for the third quarter ended September 30, 2018.

Ra Pharmaceuticals, Inc. (Nasdaq:RARX) today announced financial results for the third quarter ended September 30, 2018 and highlighted recent progress in advancing its pipeline programs, including zilucoplan for the treatment of generalized myasthenia gravis (gMG), paroxysmal nocturnal hemoglobinuria (PNH), and complement-mediated renal disorders.

Protagonist Therapeutics, Inc. (NASDAQ:PTGX) today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will provide a corporate overview at the Stifel 2018 Healthcare Conference at 8:45 a.m. EST at the Lotte New York Palace Hotel.

Corindus Vascular Robotics, Inc. announced today that management will present at two investor conferences in November as follows